AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

POLYNOVO LTD

1.260

+0.0050.40%

Volume:734.60K

Turnover:917.49K

Market Cap:870.46M

PE:66.67

High:1.262

Open:1.255

Low:1.235

Close:1.255

52wk High:2.360

52wk Low:0.930

Shares:690.84M

Float Shares:605.68M

Volume Ratio:0.38

T/O Rate:0.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.019

EPS(LYR):0.019

ROE:17.01%

ROA:4.19%

PB:10.45

PE(LYR):65.87

Loading ...

Overview Company News Filings

Stock Track | PolyNovo Soars 5.14% on Anticipation of NovoSorb Clinical Trial Results

Stock Track | PolyNovo Soars 5.14% on Trading Halt Ahead of NovoSorb Clinical Trial Results

PolyNovo Requests Trading Halt Ahead of NovoSorb Device Trial Results in Neuroischemic Diabetic Wounds

MT Newswires Live

BRIEF-Polynovo Seeks Trading Halt

Polynovo Ltd - Seeks Trading Halt Due to Clinical Trial Results on Novosorb Btm

THOMSON REUTERS

PolyNovo Limited (ASX:PNV) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable

Simply Wall St.

Stock Track | PolyNovo Soars 5% as JPMorgan Boosts Stake and Chairman Buys Shares

ASX Midday Sector Update: Real Estate Stocks Jump, Healthcare Falls

MT Newswires Live

Polynovo Chair Buys Nearly AU$52,000 Worth of Shares

MT Newswires Live

PolyNovo Says JPMorgan Chase Increases Stake

MT Newswires Live

Stock Track | Polynovo Soars 5.32% as Macquarie Predicts 40% Upside Potential

BUZZ-Australia's Polynovo tops ASX 200, eyes growth in US outpatient market

PolyNovo Says Proposed Reimbursement Plan Significant Growth Area for Products; Shares Rise 11%

MT Newswires Live

BRIEF-Polynovo Seeks Trading Halt

Polynovo Ltd - Seeks Trading Halt to Address Speculation on U.S. Reimbursement Change for Wound Care

THOMSON REUTERS

Stock Track | PolyNovo Shares Soar 5.14% Following Positive Analyst Rating and Strong Financial Performance

Wilsons Upgrades PolyNovo to Overweight from Market-Weight; Price Target is AU$1.62

MT Newswires Live

PolyNovo Posts Higher Fiscal 2025 Earnings, Revenue; Shares Up 9%

MT Newswires Live

Polynovo FY Net Income AUD 13.2 Million

THOMSON REUTERS

Stock Track | POLYNOVO Soars 5% Despite High Short Interest as Investors Anticipate Earnings Release

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PNV.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PNV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PNV.AU\",,,,,undefined,":{"symbol":"PNV.AU","market":"AU","secType":"STK","nameCN":"POLYNOVO LTD","latestPrice":1.26,"timestamp":1766466720000,"preClose":1.255,"halted":0,"volume":734600,"delay":0,"nameEN":"POLYNOVO LTD","floatShares":605679252,"shares":690842991,"eps":0.018899,"marketStatus":"Closed","change":0.005,"latestTime":"12-23 16:12:00 AEDT","open":1.255,"high":1.262,"low":1.235,"amount":917487,"amplitude":0.021514,"askPrice":1.265,"askSize":10000,"bidPrice":1.235,"bidSize":3500,"shortable":3,"etf":0,"ttmEps":0.018899,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1766530800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":1.255,"openAndCloseTimeList":[[1766444400000,1766466000000]],"volumeRatio":0.377725,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PNV.AU\",,,,,undefined,":{"symbol":"PNV.AU","floatShares":605679252,"roa":"4.19%","roe":"17.01%","lyrEps":0.01913,"volumeRatio":0.377725,"shares":690842991,"dividePrice":0,"high":1.262,"amplitude":0.021514,"preClose":1.255,"low":1.235,"week52Low":0.93,"pbRate":"10.45","psRate":"6.76","week52High":2.36,"institutionHeld":0,"latestPrice":1.26,"committee":-0.481481,"eps":0.018899,"divideRate":0,"volume":734600,"delay":0,"ttmEps":0.018899,"open":1.255,"prevYearClose":2.04,"prevWeekClose":1.23,"prevMonthClose":1.23,"prevQuarterClose":1.425,"fiveDayClose":1.17,"twentyDayClose":1.2,"sixtyDayClose":1.425},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PNV.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"PNV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-24","symbol":"PNV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740351600000,"name":null,"time":"","dateTimestamp":1740315600000,"actualEps":null},{"date":"2024-08-23","symbol":"PNV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PNV.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PNV.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1151702510","title":"Stock Track | PolyNovo Soars 5.14% on Anticipation of NovoSorb Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1151702510","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151702510?lang=en_us&edition=fundamental","pubTime":"2025-09-12 11:34","pubTimestamp":1757648070,"startTime":"0","endTime":"0","summary":"PolyNovo Ltd (ASX:PNV) shares surged 5.14% in intraday trading on Friday, as investors eagerly await the release of clinical trial results for the company's NovoSorb biodegradable temporizing matrix...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PNV.AU"],"gpt_icon":0},{"id":"1187374632","title":"Stock Track | PolyNovo Soars 5.14% on Trading Halt Ahead of NovoSorb Clinical Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1187374632","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187374632?lang=en_us&edition=fundamental","pubTime":"2025-09-12 11:34","pubTimestamp":1757648066,"startTime":"0","endTime":"0","summary":"PolyNovo Ltd (ASX:PNV) saw its stock price surge 5.14% in intraday trading on Friday, as investors reacted positively to news of an impending announcement regarding clinical trial results for the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PNV.AU"],"gpt_icon":0},{"id":"2566294468","title":"PolyNovo Requests Trading Halt Ahead of NovoSorb Device Trial Results in Neuroischemic Diabetic Wounds","url":"https://stock-news.laohu8.com/highlight/detail?id=2566294468","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566294468?lang=en_us&edition=fundamental","pubTime":"2025-09-12 11:13","pubTimestamp":1757646805,"startTime":"0","endTime":"0","summary":"PolyNovo  requested a trading halt for its securities on Friday in respect of a poster made public on the results of a chronic wound investigator-initiated clinical trial comparing the use of NovoSorb biodegradable temporizing matrix device combined with negative pressure wound therapy with the clinical standard-of-care in subjects with neuroischemic diabetic wounds, according to a same-day Australian bourse filing.NovoSorb is a synthetic, biodegradable device designed to facilitate the growth of skin tissue within a patented polyurethane matrix.The medical technology company requested the trading halt to remain in place until the release of an announcement or the opening of the market on Sept. 16.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7126","PNV.AU"],"gpt_icon":0},{"id":"2566481239","title":"BRIEF-Polynovo Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2566481239","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566481239?lang=en_us&edition=fundamental","pubTime":"2025-09-12 08:21","pubTimestamp":1757636509,"startTime":"0","endTime":"0","summary":"BRIEF-Polynovo Seeks Trading HaltSept 12 (Reuters) - Polynovo Ltd PNV.AX:SEEKS TRADING HALT DUE TO CLINICAL TRIAL RESULTS ON NOVOSORB BTMFurther company coverage: PNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UY0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PNV.AU","BK7126","BK7508"],"gpt_icon":0},{"id":"2566489729","title":"Polynovo Ltd - Seeks Trading Halt Due to Clinical Trial Results on Novosorb Btm","url":"https://stock-news.laohu8.com/highlight/detail?id=2566489729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566489729?lang=en_us&edition=fundamental","pubTime":"2025-09-12 08:20","pubTimestamp":1757636445,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nFWN3UY0G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7126","PNV.AU"],"gpt_icon":0},{"id":"2566919910","title":"PolyNovo Limited (ASX:PNV) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable","url":"https://stock-news.laohu8.com/highlight/detail?id=2566919910","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566919910?lang=en_us&edition=fundamental","pubTime":"2025-09-12 04:34","pubTimestamp":1757622842,"startTime":"0","endTime":"0","summary":"The PolyNovo Limited ( ASX:PNV ) share price has done very well over the last month, posting an excellent gain of 26...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6022000-choice2-main-header/1585186808155"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/polynovo-limited-asxpnv-stocks-shoot-up-26-but-its-pe-still","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-pnv/polynovo-shares/news/polynovo-limited-asxpnv-stocks-shoot-up-26-but-its-pe-still","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PNV.AU","BK7126","BK7508"],"gpt_icon":0},{"id":"1169178749","title":"Stock Track | PolyNovo Soars 5% as JPMorgan Boosts Stake and Chairman Buys Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1169178749","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169178749?lang=en_us&edition=fundamental","pubTime":"2025-09-11 12:42","pubTimestamp":1757565750,"startTime":"0","endTime":"0","summary":"PolyNovo Ltd (ASX: PNV) shares surged 5% in intraday trading, following two significant developments that have bolstered investor confidence in the medical devices company. The stock's impressive...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PNV.AU"],"gpt_icon":0},{"id":"2566893012","title":"ASX Midday Sector Update: Real Estate Stocks Jump, Healthcare Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2566893012","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566893012?lang=en_us&edition=fundamental","pubTime":"2025-09-11 11:32","pubTimestamp":1757561560,"startTime":"0","endTime":"0","summary":"Real estate stocks jumped a little over 1% at midday Thursday. US wholesale inflation declined in August, boosting expectations of a US Federal Reserve rate cut.Elanor Commercial Property Fund (ASX:EC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PNV.AU","BK4137","BK7154","HCSG","BK7126","BK7122","CFA.SI","BK7508","ECF.AU"],"gpt_icon":0},{"id":"2566935735","title":"Polynovo Chair Buys Nearly AU$52,000 Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2566935735","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566935735?lang=en_us&edition=fundamental","pubTime":"2025-09-11 08:10","pubTimestamp":1757549416,"startTime":"0","endTime":"0","summary":"PolyNovo  said Chairman David Williams' related entity, Moggs Creek, acquired 37,000 shares for AU$1.41 apiece, or AU$51,980 in total, via an on-market deal Wednesday, according to a Thursday filing with the Australian bourse.Williams now owns about 21.5 million shares in the company, per the filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","PNV.AU","XKO.AU","XJO.AU","BK7126","BK7508"],"gpt_icon":0},{"id":"2566935315","title":"PolyNovo Says JPMorgan Chase Increases Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2566935315","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566935315?lang=en_us&edition=fundamental","pubTime":"2025-09-11 07:55","pubTimestamp":1757548534,"startTime":"0","endTime":"0","summary":"PolyNovo  received notice that JPMorgan Chase and its affiliated entities increased their voting interest in the company to 9.99% from 7.77% on Monday, according to a Thursday filing with the Australian bourse.The bank now owns 69 million shares in the medical devices developer, the filing said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BLSP4239.USD","LU0208291251.USD","LU1084165304.USD","IE00BHPRN162.USD","LU1280957306.USD","XJO.AU","LU2237443549.SGD","IE00BWXC8680.SGD","LU0048584097.USD","LU1668664300.SGD","LU0496365809.HKD","BK4207","LU2023250504.SGD","LU0006306889.USD","LU0070302665.USD","BK4550","LU1244550221.USD","LU0251132253.USD","IE00BLSP4452.SGD","LU2237443382.USD","LU0256863811.USD","LU1496350171.SGD","LU1720051108.HKD","LU0689472784.USD","LU0683600562.USD","LU2552382132.HKD","LU0964807845.USD","PNV.AU","IE00B1XK9C88.USD","LU1894683264.USD","XKO.AU","LU0345770993.USD","LU2505996681.GBP","LU0976567544.SGD","LU0211327993.USD","IE00BDCRKT87.USD","LU2213496289.HKD","XAO.AU","LU1244550494.USD","LU2746668461.USD","LU0215105999.USD","LU0417517546.SGD","IE00BKVL7J92.USD","IE0034235295.USD","LU0203347892.USD","LU1629891620.HKD","IE00BJTD4V19.USD","IE0034235188.USD","LU1496350502.SGD","LU2430703178.SGD"],"gpt_icon":0},{"id":"1124409192","title":"Stock Track | Polynovo Soars 5.32% as Macquarie Predicts 40% Upside Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1124409192","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124409192?lang=en_us&edition=fundamental","pubTime":"2025-09-05 08:26","pubTimestamp":1757031978,"startTime":"0","endTime":"0","summary":"POLYNOVO LTD (PNV.AU) shares surged 5.32% in intraday trading, as investors reacted to Macquarie's bullish outlook on the biotech company. The stock's impressive performance comes after Macquarie...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PNV.AU"],"gpt_icon":0},{"id":"2564295898","title":"BUZZ-Australia's Polynovo tops ASX 200, eyes growth in US outpatient market","url":"https://stock-news.laohu8.com/highlight/detail?id=2564295898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564295898?lang=en_us&edition=fundamental","pubTime":"2025-09-02 09:23","pubTimestamp":1756776182,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Polynovo tops ASX 200, eyes growth in US outpatient market** Shares of medical technology co Polynovo PNV.AX rise as much as 26.6% to A$1.665, their highest point since May 14 ** Stock is top gainer in ASX 200 benchmark index .AXJO** Polynovo says outpatient wound care, for which the U.S. has proposed changes in medicare reimbursement policies, is a \"significant potential growth area\" for its products** Says it is currently assessing commercial model for accessing the outpatient opportunity** U.S. Centers for Medicare & Medicaid Services' proposed plan for flat reimbursement for outpatient skin substitutes of $806 per square inch CMS is currently under consultation** Stock has lost 28.7%, YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nL6N3UP01U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","PNV.AU","BK7508"],"gpt_icon":0},{"id":"2564282985","title":"PolyNovo Says Proposed Reimbursement Plan Significant Growth Area for Products; Shares Rise 11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2564282985","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564282985?lang=en_us&edition=fundamental","pubTime":"2025-09-02 09:19","pubTimestamp":1756775992,"startTime":"0","endTime":"0","summary":"PolyNovo  said the US Centers for Medicare & Medicaid Services' proposed reimbursement of $806 per square inch for outpatient skin substitutes is a significant potential growth area for the company's products, according to a Tuesday filing with the Australian bourse.The company said it is \"well-positioned\" to benefit from the changes, and it is assessing the optimal commercial model.A decision regarding the proposal is expected by November, the fling added.Shares of the company rose 11% in recent Tuesday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7126","PNV.AU"],"gpt_icon":0},{"id":"2564861677","title":"BRIEF-Polynovo Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2564861677","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564861677?lang=en_us&edition=fundamental","pubTime":"2025-09-01 09:52","pubTimestamp":1756691558,"startTime":"0","endTime":"0","summary":"BRIEF-Polynovo Seeks Trading HaltSept 1 (Reuters) - Polynovo Ltd PNV.AX:SEEKS TRADING HALT TO ADDRESS SPECULATION ON U.S. REIMBURSEMENT CHANGE FOR WOUND CAREFurther company coverage: PNV.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250901:nFWN3UL1KU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PNV.AU","BK7126","BK7508"],"gpt_icon":0},{"id":"2564291868","title":"Polynovo Ltd - Seeks Trading Halt to Address Speculation on U.S. Reimbursement Change for Wound Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2564291868","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564291868?lang=en_us&edition=fundamental","pubTime":"2025-09-01 07:34","pubTimestamp":1756683253,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250831:nFWN3UL1KU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","PNV.AU","BK7508"],"gpt_icon":0},{"id":"1159027326","title":"Stock Track | PolyNovo Shares Soar 5.14% Following Positive Analyst Rating and Strong Financial Performance","url":"https://stock-news.laohu8.com/highlight/detail?id=1159027326","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159027326?lang=en_us&edition=fundamental","pubTime":"2025-08-27 09:16","pubTimestamp":1756257380,"startTime":"0","endTime":"0","summary":"Shares of PolyNovo Ltd (PNV.AU) surged 5.14% in intraday trading on Wednesday, as investors responded positively to recent analyst recommendations and the company's strong financial performance. The...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PNV.AU"],"gpt_icon":0},{"id":"2562778906","title":"Wilsons Upgrades PolyNovo to Overweight from Market-Weight; Price Target is AU$1.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562778906?lang=en_us&edition=fundamental","pubTime":"2025-08-26 17:16","pubTimestamp":1756199766,"startTime":"0","endTime":"0","summary":"Wilsons Upgrades PolyNovo to Overweight from Market-Weight; Price Target is AU$1.62","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PNV.AU"],"gpt_icon":0},{"id":"2562829446","title":"PolyNovo Posts Higher Fiscal 2025 Earnings, Revenue; Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562829446","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562829446?lang=en_us&edition=fundamental","pubTime":"2025-08-25 11:31","pubTimestamp":1756092718,"startTime":"0","endTime":"0","summary":"PolyNovo  reported Monday fiscal 2025 earnings of AU$0.0189 per share, up from AU$0.0075 a year earlier.Analysts polled by FactSet expected earnings of AU$0.01.Revenue for the 12 months ended June 30 was AU$129.2 million, compared with AU$104.8 million a year earlier. Analysts surveyed by FactSet expected AU$118.6 million.Shares rose nearly 9% in afternoon trade Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PNV.AU"],"gpt_icon":0},{"id":"2562144296","title":"Polynovo FY Net Income AUD 13.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2562144296","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562144296?lang=en_us&edition=fundamental","pubTime":"2025-08-25 09:46","pubTimestamp":1756086415,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nPLXC71ED0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","PNV.AU","BK7508"],"gpt_icon":0},{"id":"1177387769","title":"Stock Track | POLYNOVO Soars 5% Despite High Short Interest as Investors Anticipate Earnings Release","url":"https://stock-news.laohu8.com/highlight/detail?id=1177387769","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177387769?lang=en_us&edition=fundamental","pubTime":"2025-08-25 08:26","pubTimestamp":1756081592,"startTime":"0","endTime":"0","summary":"POLYNOVO LTD (PNV.AU), the Australian medical device company, saw its stock price surge by 5.00% in Monday's pre-market trading, defying its position as one of the most shorted stocks on the ASX....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["PNV.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}]}}